Aurinia Pharmaceuticals Inc. (AUPH) stock
AUPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 13/3062% below fair value
$15.73−0.48 (-2.96%)
Close on Nov 13, 2026Market cap $2.11BP/E 6.9Yield –
Aurinia Pharmaceuticals statistics
91 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 25, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 3.22
- 2.22
- P/OCF Ratio
- 11.90
- 12.99
Enterprise valuationIndustry
- EV / Sales
- 6.41
- 2.57
- EV / EBIT
- 13.19
- 19.31
Share statisticsIndustry
- Shares Change (YoY)
- -3.92%
- 10.8%
- Shares Change (QoQ)
- 0.82%
- 0.50%
- Float
- 111M
- 49M
- Shares Held by Insiders
- 17.3%
- 11.7%
- Shares Held by Institutions
- 58.3%
- 56.4%
Short sellingIndustry
- Short Interest
- 7M
- –
- Short Interest Change
- -8.26%
- -0.80%
- Short % of Float
- 6.44%
- 9.01%
- Short % of Shares Outstanding
- 5.33%
- 6.30%
- Days to Cover
- 10.31
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $19.25
- –
- 52-Week Low
- $13.52
- –
- 20-Day Moving Average
- $16.67
- –
- 50-Day Moving Average
- $16.48
- –
- 200-Day Moving Average
- $15.73
- –
- Average True Range (14)
- $0.52
- –
- Price Change (1 Week)
- -4.43%
- -1.15%
- Price Change (1 Month)
- -5.98%
- -4.87%
- Price Change (3 Months)
- 2.88%
- -21.0%
- Price Change (6 Months)
- 2.95%
- -20.6%
- Price Change (YTD)
- -1.38%
- -23.6%
- Price Change (1 Year)
- 1.22%
- -22.4%
- Price Change (3 Years)
- 92.5%
- -29.5%
- Price Change (5 Years)
- -47.1%
- -77.9%
- Price Change (10 Years)
- 369.6%
- -65.4%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 903,494
- –
- Average Volume (90 Days)
- 958,283
- –
- Relative Volume
- 0.71
- 0.70
- Relative Strength Index (14)
- 39.9
- 43.4
- Volatility (1 Year)
- 35.5%
- 80.1%
- Beta (5 Years)
- 1.06
- 1.07
MarginsIndustry
- Pretax Margin
- 51.9%
- -11.6%
- EBITDA Margin
- 54.6%
- -27.7%
Returns on capitalIndustry
- Return on Equity (ROE)
- 61.4%
- -49.9%
- Return on Assets (ROA)
- 46.4%
- -40.6%
- Return on Invested Capital (ROIC)
- 34.6%
- -32.9%
- Return on Capital Employed (ROCE)
- 21.4%
- -37.9%
Financial positionIndustry
- Current Ratio
- 6.12
- 3.30
- Quick Ratio
- 0.48
- 2.39
- Interest Coverage
- 40.36
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 21.0%
- 6.82%
- Net Income Growth (YoY)
- 303.7%
- -14.4%
- EPS Growth (YoY)
- 308.9%
- -12.3%
- Revenue Growth (3Y CAGR)
- 28.3%
- 2.25%
- Revenue Growth (5Y CAGR)
- 41.4%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.48
- 0.40
- Inventory Turnover
- 0.68
- 2.73
- Revenue Per Employee
- $2.51M
- $429.29K
- Profits Per Employee
- $2.46M
- -$689.41K
- Employee Count
- 128
- 74
- WACC
- 10.4%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- $167.12M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $45.79M
- $17.76M
- Net Cash Per Share
- $0.34
- $0.80
- Equity (Book Value)
- $657.52M
- $53.89M
- Book Value Per Share
- $4.91
- $1.50
- Tangible Book Value
- $654.35M
- $27.13M
- Working Capital
- $491.88M
- $79.99M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- 14.9%
- -21.8%
- Buyback Yield
- 3.55%
- -0.76%
- Shareholder Yield
- 3.55%
- 0.00%
Taxes and interestIndustry
- Interest Expense
- $3.87M
- $2.90M
- Income Tax
- -$147.15M
- $73.00K
- Effective Tax Rate
- -88.1%
- 20.9%
Scores and fair valueIndustry
- Graham Number
- $15.90
- $19.34
- Graham Upside
- 1.08%
- -46.6%
- Altman Z-Score
- 8.32
- 0.23
- Piotroski F-Score
- 8
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | AUPH | S&P 500 | Difference | AUPH per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -3.9% | -3.0% | −0.8 pts | ||
| 3 months | +3.6% | -2.8% | +6.4 pts | ||
| Year to date | -1.4% | +11.5% | −12.9 pts | ||
| 1 year | +3.4% | +13.5% | −10.1 pts | ||
| 3 years | +101.2% | +77.7% | +23.5 pts | +26.2% | +21.1% |
| 5 years | -47.1% | +72.6% | −119.8 pts | -12.0% | +11.5% |
| 10 years | +402.6% | +308.2% | +94.4 pts | +17.5% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
7M AUPH shares were sold short on Oct 30, 2026, down 8.3% from the previous report, or 6.44% of the shares available to trade. At recent volumes it would take 10.3 days to buy them back. Over the last 20 sessions, 36.2% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 7,137,632 | -8.3% | 692,192 | 10.3 |
| Oct 15, 2026 | 7,780,313 | -1.8% | 868,490 | 9.0 |
| Sep 30, 2026 | 7,920,606 | -7.6% | 844,517 | 9.4 |
| Sep 15, 2026 | 8,576,505 | -4.5% | 774,118 | 11.1 |
| Aug 31, 2026 | 8,978,748 | -6.6% | 1,048,882 | 8.6 |
| Aug 14, 2026 | 9,615,436 | +0.9% | 1,205,103 | 8.0 |
| Jul 31, 2026 | 9,525,730 | -1.9% | 1,009,010 | 9.4 |
| Jul 15, 2026 | 9,714,642 | +1.3% | 1,684,047 | 5.8 |
| Jun 30, 2026 | 9,589,939 | +3.6% | 2,473,332 | 3.9 |
| Jun 15, 2026 | 9,252,751 | +4.9% | 1,209,589 | 7.7 |
| May 29, 2026 | 8,820,725 | -2.3% | 1,120,068 | 7.9 |
| May 15, 2026 | 9,024,992 | +1.6% | 1,328,337 | 6.8 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?